Icon

DAWNZERA (AUTOINJECTOR) - (80MG/0.8ML)

DONIDALORSEN SODIUM None
80MG/0.8ML
Less Than $1000 mn
None None
None None
None None
DAWNZERA is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Yes
DAWNZERA (AUTOINJECTOR) Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.